Metastases in the small intestine from a subcutaneous lower limb leiomyosarcoma.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to K Breivik.
Explore the source record for details and available documents.
We present 40 patients operated consecutively for pyloric stenosis during an 8-year period (1981-88). The most common symptom was projectile vomiting, which occurred in 92.5% of the cases. On examination only three patients had a palpable hypertrophic pylorus. In 39 patients, a preoperative x-ray examination with contrast was necessary to confirm the diagnosis. A pyleromyotomy was performed in all patients. We discuss the diagnostic routines and the results of our treatment.
Explore the source record for details and available documents.
The mental and physical capacity of all residents in homes for aged people were estimated, and their neuroleptic drug consumption and duration of stay were registered. One third was moderately to severely mentally impaired and 38% demanded more extensive nursing care. Physical dependence was significantly associated with mental decline, and less with age. One quarter of severely mentally impaired people had stayed for less than one year; 23% of the residents received neuroleptic drugs. Treatment was more common in physically incapacitated people together with wandering and aggressive ones. Lack of psychogeriatric services may enhance the use of neuroleptic drugs in homes for aged people.
The relationship between rate response and exercise tolerance was studied by measuring the symptom-limited maximum treadmill time (MTT)both during fixed rate VVI pacing and during VVI + activity mode pacing (RRP) in 15 patients (mean age, 73 years) who had received rate-responsive ventricular pacemakers. Their indications were atrioventricular block, sino-atrial block, and atrial fibrillation with slow ventricular response. Basic rate was programmed to 60 ppm in both pacing modes; rate response and activity threshold were programmed to 5 and medium, respectively. The order in which the two pacing modes were tested was randomly determined. The MTT was, on average, 29% longer in RRP than in VVI mode with a mean of 12 minutes in VVI and 14.8 minutes in RRP (p less than 0.001). For the subgroup of eight patients with paced-only rhythm the average increase in MTT was 38% with a mean of 9.5 minutes in VVI and 12.8 minutes in RRP (p less than 0.01). Seven patients who showed episodes of spontaneous rhythm, increased their average MTT by 17% (mean in VVI, 14.9 minutes; in RRP, 17.1 minutes; p less than 0.02). During RRP, a significant positive correlation existed between MTT and the increase in heart rate (N = 15; r = 0.83; p less than 0.001). In 12 patients with paced-only rhythm, the pacing rate remained at the programmed basic rate when the patients were lying, sitting, and standing and increased to 86 +/- 4 ppm during casual walking, and to 101 +/- 4 ppm during jumping up and down with the pacemaker programmed to the above-mentioned parameters. The maximum pacing rate during jumping corresponded with the maximum pacing rates measured from Holter recordings during normal daily activities.
Dementia and work load were estimated in 4736 elderly home-nursed or institutionalized persons. Mental status was estimated by means of the Clinical Dementia Rating scale (CDR), and work load by means of a traditional work load scale. Approximately one third of elderly over 85 years were living in an institution. 4.6% of the population over 65 years of age were moderately to severely and 1.8% mildly demented. Work load increased with increasing dementia. In homes for the aged 40% and in nursing homes 85% of the residents create a heavy work load. 14.5% of the estimated population are considered misplaced, the majority of whom should be transferred to a higher care level. Dementias cause a major problem on every care level. Services which are lacking for this group and necessary rehabilitation facilities should be provided.
Explore the source record for details and available documents.
Of 693 patients on permanent pacemaker treatment between 1962 and 1981, 282 (40.7%) were above the age of 75. Of this number, 142 patients were 75-79 years, 95 80-84 years and 45 85-93 (mean 87) years old at the time of the first pacemaker implantation. The patients were followed for 13-154 months (mean 37.1) with special attention being paid to morbidity and mortality after the implantation. Complications occurred in 65 (23%) of the elderly patients, with no significant difference between the three age groups. Excessive threshold rise with stimulation failure (6%) and infections or skin erosions (4.9%) were the most frequent complications. Mortality increased in all age groups during the first 6-12 months compared with the age- and sex-matched Norwegian population. Five-year survival rates were 56, 32 and 25% respectively. We conclude that cardiac pacemaker treatment in the elderly is a safe symptom-relieving therapeutic procedure and that the prognosis for these patients is similar to that for their fellow senior citizens after the first year of treatment.
Over a six-month period a comparison was made between uni- and bipolar myocardial stimulation thresholds and R-wave sensitivity in 15 consecutive pacemaker patients. The patients received a new multiprogrammable Cordis 336 A pulse generator, that could be programmed with either uni- or bipolar circuitry. In addition, rate, output, sensitivity and pacing mode could be noninvasively programmed. The occurrence of myopotential interference at different sensitivity levels was also studied. Cordis 325-161 bipolar endocardial leads were used in all patients. In one patient, the current output sometimes had to be programmed higher bipolarly than unipolarly to capture the ventricles, otherwise no differences in threshold were found. Acutely. R-wave sensitivity was superior in 9 patients (60%) in the bipolar mode. Unipolar and bipolar electrograms were equal in 4 (26.7%), whereas unipolar R-wave sensitivity was best in only 2 (13.3%) of the patients. At a six-month follow-up, the same tendency was found. In 5 patients, bipolar sensing was superior to unipolar, while anti- and bipolar sensitivity was equal in the remaining patients. Myopotential inhibition was never seen in the bipolar mode at highest sensitivity (0.8 mV) even during provocative tests (n = 15) or 24-hour Holter monitoring (n = 12). In the unipolar mode, 14/15 patients (93.3%) showed inhibition during provocative tests and 12/12 patients (100%) during monitoring at a programmed sensitivity of 0.8 mV. No patients had myopotential interference at a sensitivity level of 3.5 mV. All patients have their pacemakers programmed in the bipolar mode after six months. This study confirms earlier acute data that the bipolar pacing mode is superior to the unipolar mode for permanent pacemaker therapy.
A new temporary pacing lead. Medtronic Model 6400, with a defined electrode surface area of 7.5 mm2, has been clinically and electrophysiologically evaluated during bipolar atrial application in 20 patients after cardiac operations. A silicon disc was used for fixation of the electrodes to the right atrium in 10 patients, and an atrial plication technique was used in the other 10. Myocardial stimulation threshold and resistance were measured throughout the postoperative period. Atrial electrograms were recorded on magnetic tape for computer analysis of amplitudes, slew rates, and signal source impedance. No significant differences (p greater than 0.1) were found in myocardial stimulation threshold between the two fixation modes. During constant-current pacing, median threshold rose from 0.65 mA to 2.3 mA. Stimulation resistance, measured during constant-voltage pacing, fell from 567 to 365 omega, with a subsequent rise to 425 omega before electrode removal. Again no difference was found between silicon disc and plication fixation of the electrodes. P-wave amplitudes were significantly higher with plication than with silicon disc fixation (2.26 versus 0.86 mV, p less than 0.01), as were slew rates (0.34 versus 0.18 V/s, p less than 0.05). Signal source impedance had a magnitude of 6 k omega. The electrodes were used successfully in 12 (60%) of the patients for diagnosis and/or treatment of arrhythmias. We find the new lead well suited for atrial application.
Unipolar and bipolar electrode systems were compared for electrogram amplitudes and slew rates, signal source impedance, and myocardial stimulation threshold and resistance in 15 consecutive patients who received a new endocardial electrode (Cordis 325-161). The bipolar electrograms showed the highest amplitude in nine of the patients (60%). The unipolar and bipolar electrograms were equal in four patients (26.7%), whereas the unipolar electrograms were highest in only two patients (13.3%). The difference in mean amplitude between bipolar (11.1 mV) and unipolar (10.1 mV) electrograms was statistically significant (p 0.05). Mean slew rates were almost equal (1.7 versus 1.6 V/s; p greater than 0.1). The bipolar electrode system always gave somewhat higher signal source impedance than the unipolar system (p 0.001). The current threshold was significantly lower during bipolar pacing (0.59 mA) in constant current pacing mode, than during unipolar pacing (0.65 mA) (p less than 0.05). No significant differences were found during constant voltage pacing. Stimulation resistance was highest in the bipolar electrode system (p less than 0.001). We conclude that the bipolar electrode system is as good as, or better than, the unipolar system both for ventricular sensing and for pacing.
From a total of 51 patients equipped with rate and pulse width adjustable pulse generators (Microlith-P 0505, Microthin-PI 0522) implanted over the last 3 years, 10 (19.6%) showed an unexpected drop in pacemaker pulse rate during pulse width programming. For one of the pulse generators used (Microthin-PI 0522), unexpected rate decrease occurred in 7/13 cases (53.8%). For all except one patient, decrease in pacemaker pulse rate corresponded with the total refractory period of the pulse generator ( 320 ms), at a certain pulse width when rate drop first occurred. In seven of the patients the pulse generator automatic interval was extended from 13 ms to 171 ms beyond the refractory period. In two patients it was necessary to replace the pulse generators. Our study strongly proves that this abnormal pacemaker functioning is a result of sensing of the polarization voltage at the pacemaker electrode/tissue interface and/or the T-wave. The polarization voltage is highly dependent on the total pacemaker electrode/tissue interface impedance. Using typical values for pulse generator output and input resistance and output capacitance, Faraday resistance, Helmholtz capacitance and tissue resistance at the electrode/tissue interface it was shown mathematically that in some cases the polarization voltage alone would be of sufficient amplitude and slew rate for pacemaker inhibition. The study demonstrates an urgent need for change in the filter characteristics by making the pulse generators less sensitive in the low frequency region and reducing the polarization voltage by reducing the output circuit capacitance.
A new temporary pacemaker lead, Medtronic 6400, with a solid defined electrode surface area of 7.5 mm2, has been implanted in 50 patients after open-heart surgery. One electrode was inserted intramyocardially on the right ventricle, while another was placed extracardially and served as a reference lead. Forty-six of the patients were followed postoperatively with measurements of myocardial stimulation threshold and resistance. In 25 of the patients, electrograms were recorded on magnetic tape for further computer analysis of amplitudes, slew rates, and signal source impedance. During constant current pacing, myocardial stimulation threshold increased from a median of 0.4 mA one hour postoperatively to a maximum value of 2.3 mA. In two patients (4.3%) intermittent pacing failure was seen. Stimulation resistance fell from a median of 875 omega to a minimum of 487 omega, with a subsequent increase of 598 omega before electrode removal. Both mean electrogram amplitude (7.35 mV) and slew rate (0.82 V/s) had their minimum values on the sixth postoperative day. Intermittent sensing failure was observed in 2/25 patients (8%). Signal source impedance was of a magnitude not likely to contribute to sensing failure. No complications were seen from the use of this lead. The new electrode is an important improvement in temporary pacemaker lead design.
Sixty-one patients given programmable pacemakers at initial implantation have been followed for a mean of 18 months (3-42) with non-invasive measurements of myocardial pulse-width threshold. Fifty of the patients had CPI 0505/0522 (Microlith-P/Microthin-PI) pacemakers with either Cordis 322-462 8 mm2 ball tip (n=12), Cordis 322-620 17.5 mm2 (n=23), or CPI 4116 porous tip electrodes (stimulation area 7.5 mm2 and sensing area 50 mm2) (n=15). Eleven patients had Medtronic 5985 (Spectrax-SX) pacemakers with either Medtronic 6907-R 8 mm2 ring tip (n=7), 6907 11 mm2 (n=3) or 6917 myocardial electrodes (area 12 mm2) (n=1). At acute implant, the ball tip and porous tip electrodes had the lowest stimulation thresholds, but the differences were only statistically significant in comparison with the 17.5 mm2 electrode (p less than 0.01). Chronically there were no significant differences between the various electrodes (p greater than 0.1), but the ball tip electrode tended to give best long-term results, and the porous tip electrode the poorest. Thirty-eight of the 61 patients (62.3%) had chronic pulse-width thresholds of 0.1 ms or less at approximately equal to 5 V output, indicating that pulse-width programming is a useful way to conserve battery energy. However, at some stage of the study, six of the patients (9.8%) had a pulse-width threshold of 0.5 ms or more. Pulse width should therefore not be set too narrow in standard nonprogrammable pacemakers.
A Holter monitor study was performed to assess the occurrence of spontaneous heart activity in 70 pacemaker treated patients (mean age 72.1 years) with high-grade atrioventricular (AV) block, who have been treated with permanent pacemakers for a mean of 60 months (range 5-161). Nineteen patients had asynchronous (VOO), and 51 QRS-inhibited (VVI) pacemakers. The patients were monitored for a mean of 23 hours (range 15.5-26). Twenty-five patients were re-studied for day-by-day variations in spontaneous heart activity. At clinical observation, thirty-eight patients had some kind of spontaneous cardiac activity, mostly ventricular ectopic beats. Three patients had short episodes of sinus rhythm of more than 70 beats/min. Patients in functional class III-IV (NYHA) or with an enlarged heart had the most spontaneous heart activity. No tachyarrhythmias precipitated by interference between intrinsic heart beats and asynchronous pacemakers were seen. Twenty patients studied twice had a relatively stable occurrence of spontaneous heart activity, while five (20%) varied considerably. On the basis of these long-term observations it is difficult to predict when interference rhythm will occur, and asynchronous pacemakers therefore cannot be recommended for the first implantation.
Seventy-four patients with unipolar QRS-inhibited pacemakers (VVI) were Holter monitored to assess the occurrence of pacemaker inhibition caused by skeletal muscle potentials during daily activities. Fifty patients had high-grade atrioventricular block and 24 had sinoatrial disease. Chest wall stimulation prior to monitoring revealed asystole of > 4 seconds duration in 22 patients, and ventricular rates between 25 and 56 beats per minute in 52 patients. Fifty-one patients (69%) had one or more episodes of pacemaker inhibition from myopotentials. Inhibition occurred in all types of pacemakers studies, but was most frequent and of longest duration in patients with Siemens-Elema 207/70 (13/14 patients), Cordis Omni-Stanicor (6/7 patients), CPI Microlith (5/6 patients), and Medtronic 5945 (8/10 patients). This was not unexpected considering the filter characteristics of the pacemakers. Nine patients (12%) presented symptoms which might be ascribed to pacemaker inhibition. The longest asystole observed was 3.2 s. Seven patients had pacemakers spikes falling on or near T-waves of spontaneous heart beats because their pacemakers had been rendered refractory by myopotentials. No serious arrhythmias were seen during episodes of pacemaker inhibition or interference. More emphasis should be put on the improvement of filter characteristics of unipolar VVI-pacemakers. Pacemaker patients with symptoms of myopotential inhibition should be equipped with either a bipolar or ventricular triggered (VVT) pacemaker or with a sensitivity and/or pacing mode programmable pacemaker.
Explore the source record for details and available documents.
During the last decade implantation of permanent pacemakers has become the treatment of choice for patients suffering from the sick sinus syndrome (SSS). We have followed up 112 SSS patients treated with permanent pacemakers in Haukeland Hospital in the period 1966--76. The pacemakers were later removed from three of the patients. In the remaining 109 patients the SSS was characterized by tachy-bradyarrhythmias (TBA) in 44 and bradyarrhythmias (BA) in 65. Before implantation, 68 patients had syncopes and 27 severe dizziness. After implantation, symptomatic improvement was apparent in 104 patients; only three still had syncopes. During the follow-up period (mean 34.4 months), 29 patients died (yearly mortality 9.3%). There was no significant difference in total mortality between patients with TBA and with BA. Concomitant disturbances in atrioventricular (AV) conduction occurred in 35.8% of the patients. Among 79 of 80 patients still alive, five had developed total AV block, 19 had stable atrial fibrillation, 12 of these were possibly pacemaker-independent (ventricular rate greater than 60/min). Systemic embolization was observed in 16 patients, more frequently in the TBA (12/44) than in the BA group (4/65) (p less than 0.001). It is concluded that permanent pacemakers have an excellent symptomatic effect in patients with SSS. The prognosis is mainly determined by the presence or absence of coronary heart disease and/or heart failure.